Cooper Companies (COO) PT Raised to $210 at Jefferies Following Lens Survey
- DuPont (DD) Tops Q4 EPS by 9c; Sees Merger Closing in First Half
- Barclays Downgrades Apple (AAPL) to Equalweight, Concerned India/China Will not Emerge As Growth Catalysts
- Yahoo! (YHOO) Tops Q4 EPS by 4c; Sees Verizon Deal Closing in Q2, Not Q1
- SAP (SAP) Q4 IFRS Revenues Rises 7%, Boosts 2020 Outlook
- Oppenheimer Downgrades Energous Corp (WATT) to Perform
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Jefferies analyst Anthony Petrone reiterated a Buy rating and lifted his price target on Cooper Companies (NYSE: COO) to $210.00 (from $190.00) saying a lens survey showed clariti/MyDay are poised for more gains while Vita is off to a slow start.
Petrone commented, "We conducted a follow-up survey of 52 new optometry practices in order to gauge trends ahead of COO’s F3Q16 (July) print. Key findings are: 1) clariti/ MyDay combo still poised for share gains; 2) JNJ’s Acuvue Vita is off to slow start with a less than 4% uptake; 3) Shift in monthlies is mostly at expense of 2-week lenses; 4) Biofinity appears stable. FX could add up to $0.50 through year-end."
The firm raised Q3 EPS estimates on Cooper Companies from $2.26 to $2.30, FY 2016 EPS estimates to $8.30 to $8.48 and FY 2017 EPS estimates form $9.65 to $9.85.
Shares of Cooper Companies closed at $185.79 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Instinet Downgrades DineEquity (DIN) to Neutral
- Perrigo (PRGO): Cutting 2017 EPS On Weaker Generics - Guggenheim
- Procter & Gamble (PG) PT Raised to $99 at Jefferies Following 2Q Beat
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS Change, Analyst PT Change
Related EntitiesJefferies & Co
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!